Search

Vaccination programmes provide a safe, effective and cost‐efficient strategy for maintaining population health. In veterinary medicine, vaccination not only reduces disease within animal populations but also serves to enhance public health by targeting zoonoses. Nevertheless, for many pathogens, an effective vaccine remains elusive. Recently, nanovaccines have proved to be successful for various infectious and non‐infectious diseases of animals. These novel technologies, such as virus‐like particles, self‐assembling proteins, polymeric nanoparticles, liposomes and virosomes, offer great potential for solving many of the vaccine production challenges. Their benefits include low immunotoxicity, antigen stability, enhanced immunogenicity, flexibility sustained release and the ability to evoke both humoral and cellular immune responses. Nanovaccines are more efficient than traditional vaccines due to ease of control and plasticity in their physio‐chemical properties. They use a highly targeted immunological approach which can provide strong and long‐lasting immunity. This article reviews the currently available nanovaccine technology and considers its utility for both infectious diseases and non‐infectious diseases such as auto‐immunity and cancer. Future research opportunities and application challenges from bench to clinical usage are also discussed. [ABSTRACT FROM AUTHOR]

The development of eco-friendly and nontoxic processes for the synthesis of nanoparticles is one of the most important discussed issues in nanotechnology science. This study reports the green synthesis of silver nanoparticles (AgNPs) using aqueous extract of leaf, stem, and root of Avicennia marina, the native and dominant mangrove plant in southern Iran. Among the different plant parts, the extract of leaves yielded the maximum synthesis of AgNPs. Synthesized AgNPs were investigated using UV-visible spectrophotometry, transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), energy-dispersive spectroscopy (EDS), and Fourier transform infrared (FTIR) spectroscopy. Absorption spectrum in 420 nm confirmed the synthesis of AgNPs. TEM images revealed that the synthesized AgNPs had the same spherical morphology with a size range between 0 and 75 nm. The distribution size histogram indicated that the most frequent particles were in the range of 10-15 nm and the mean size of nanoparticles was 17.30 nm. The results of SEM image showed nanoparticles with a size range between 15 and 43 nm. XRD pattern indicated the crystalline nature of synthesized nanoparticles. EDS results confirmed the presence of elements like silver, carbon, chlorine, nitrogen, and oxygen in the nanoparticles produced from leaf extract. Silver had the maximum percentage of formation, 51.6%. FTIR indicated the presence of different functional groups such as amines, alcohol, alkanes, phenol, alkyl halides, and aromatic loops in the synthesis process. Green biosynthesis of AgNPs using aqueous extract of native A. marina appears rapid, reliable, nontoxic, and eco-friendly. [ABSTRACT FROM AUTHOR]

In recent years, gold nanoparticles (Au‐NPs) have been taken into consideration in nanomedicine due to their excellent biocompatibility, chemical stability and promising optical properties. In this research, podophyllotoxin conjugated with gold nanoparticles (Au‐NPs‐POT) was synthesized and the conjugation of POT with Au‐NPs was confirmed using scanning electron microscopy, mass spectrometry and Fourier transform infrared spectroscopy. The anticancer effects of the product on preclinical models of lung, colon and breast cancers were investigated using MTT test. The analyses showed a direct dose–response relationship. It was found that higher concentrations of POT have more positive effects on the inhibition of cancer cell growth. At POT concentrations of 1, 2.5, 5, 7.5, 10, 15 and 20 ng ml−1, approximately 50% of the growth of colorectal, lung and breast cancer cell lines was inhibited, while similar results were obtained in the presence of 1, 2, 3, 4 and 5 μg ml−1 Au‐NPs‐POT. Au‐NPs‐POT exhibited the lowest cytotoxicity due to the presence of POT. The anticancer feature of Au‐NPs‐POT proved the potential to develop better anticancer therapeutics and to open new avenues for treatment of cancers. [ABSTRACT FROM AUTHOR]